2026 Interim report
Filed with HKEX · Stock code 2697 · · 53 pages · English
Definitions 2 Corporate Information 7 Management Discussion and Analysis 8 R&D and Product Pipeline 10 Financial Review 17 Corporate Governance and Other Information 27 Interim Condensed Consolidated Statements of Profit or Loss and Other Comprehensive Income 33 Interim Condensed Consolidated Statements of Financial Position 34 Interim Condensed Consolidated Statements of Changes in Equity 36 Inte
Guangdong True Health Medical Technology Development Co. Ltd. on 6ix
Earlier from Guangdong True Health Medical Technology Development
- Announcement of final offer price and allotment results
- List of Directors and their Roles and Functions
- Documents on Display
- PHIP (1st submission)
Later from Guangdong True Health Medical Technology Development
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Voluntary Announcement on Significant Progress in Research on Extracorporeal Liver Perfusion Support Therapy Using an Organ Perfusion System
Follow Guangdong True Health Medical Technology Development into a list and get an email when it puts out news.
Follow Guangdong True Health Medical Technology Development